The immunogenicity of dendritic cell-derived exosomes

被引:126
|
作者
Quah, BJC [1 ]
O'Neill, HC [1 ]
机构
[1] Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia
基金
英国医学研究理事会;
关键词
exosomes; dendritic cells; T cell activation; tumour immunity;
D O I
10.1016/j.bcmd.2005.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exosome production represents an alternate endocytic pathway for secretion. Multivesicular endosomes (MVE) fuse with the plasma membrane expelling internal vesicles or exosomes from cells. Exosome production has been recently described for immune cells including B cells, dendritic cells (DC), mast cells, macrophages and T cells. Exosomes derived from some DC populations stimulate T lymphocyte proliferation in vitro and have potent capacity to generate anti-tumour immune responses in vivo. These reported studies have involved in vitro grown mature DC expanded from precursors with cytokines. However, immature DC produce higher numbers of exosomes than mature DC and this is thought to be due to a reduction in endocytosis as DC mature, associated with reduced reformation of MVE and reduced exosome formation. This lab pioneered a method to generate immature DC in spleen long-term cultures (LTC). DC produced in cultures represent immature myeloid DC, highly endocytic but with weak capacity to stimulate T cells. LTC-DC produce exosomes and contain many MVE. This prompted a study of immunogenic potential with a view to the potential use of exosomes in vaccination and immunotherapy. DC produced in cultures represent immature myeloid DC, highly endocytic but with weak capacity to stimulate T cells. Exosomes were isolated by differential centrifugation from LTC-DC and shown by marker expression to arise by budding from the LAMP-1(+) limiting endosomal membrane of MVE. These LTC-derived exosomes appear however to lack immunostimulatory markers like CD86, CD40, MHC-I and MHC-II. While LTC-DC can stimulate antigen-specific proliferation of CD4(+) T cells, exosome preparations derived from antigen-pulsed DC were unable to stimulate purified naive T cells in vitro. They were however found to weakly activate allogeneic CD8(+) T cells in vitro. Tumour antigen-pulsed LTC-DC or their exosomes could induce a protective response in mice against growth of a transplanted tumour but could not induce a response to clear an existing tumour. Exosomes derived from immature DC can modulate immune responses, but do not function in direct T cell activation in vitro. Modulation of immune responses by exosomes produced by immature DC may be dependent on the presence of other antigen presenting DC subsets in the animal. The possible function of immature DC and their exosomes in maintenance of tolerance and in the induction of immunity is discussed. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:94 / 110
页数:17
相关论文
共 50 条
  • [1] Dendritic cell-derived exosomes for cancer therapy
    Pitt, Jonathan M.
    Andre, Fabrice
    Amigorena, Sebastian
    Soria, Jean-Charles
    Eggermont, Alexander
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (04): : 1224 - 1232
  • [2] Antitumoral immunotherapy by dendritic cell-derived exosomes
    Regnault, A
    Raposo, G
    Amigorena, S
    Zitvogel, L
    [J]. M S-MEDECINE SCIENCES, 1998, 14 (6-7): : 826 - 827
  • [3] Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
    Luo, Shumin
    Chen, Jing
    Xu, Fang
    Chen, Huan
    Li, Yiru
    Li, Weihua
    [J]. PHARMACEUTICS, 2023, 15 (08)
  • [4] Dendritic cell-derived exosomes are suppressed tumor growth
    Takanashi, Masakatsu
    Ueda, Shinobu
    Mitsuda, Yumi
    Sudo, Katsuko
    Ishikawa, Akio
    Kuroda, Masahiko
    [J]. CANCER SCIENCE, 2018, 109 : 282 - 282
  • [5] Cancer immunotherapy using dendritic cell-derived exosomes
    Amigorena, S
    [J]. MEDICINA-BUENOS AIRES, 2000, 60 : 51 - 54
  • [6] Dendritic cell activation by tumor cell-derived exosomes.
    Ilett, Liz
    Errington, Fiona
    Morgan, Ruth
    Vile, Richard
    Selby, Peter
    Melcher, Alan
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S149 - S150
  • [7] Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges
    Tian, Hong
    Li, Wei
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (10)
  • [8] REVIEW: The application of dendritic cell-derived exosomes in tumour immunotherapy
    Quah, B
    O'Neill, HC
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2000, 15 (02) : 185 - 194
  • [9] Engineering dendritic cell-derived exosomes forbrain metastases immunotherapy
    Chen, Hao-Nien
    Yuan, Xiangliang
    Duan, Yimin
    Xiao, Yi
    Yang, Shao-Ping
    Yu, Dihua
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [10] Role of dendritic cell-derived exosomes in allergic rhinitis (Review)
    Kang, Chenglin
    He, Haipeng
    Liu, Peng
    Liu, Yue
    Li, Xiaomei
    Zhang, Jin
    Ran, Hong
    Zeng, Xianhai
    Zhao, Hailiang
    Liu, Jiangqi
    Qiu, Shuqi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2023, 52 (06)